Instil Bio Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Instil Bio's earnings have been declining at an average annual rate of -23.5%, while the Biotechs industry saw earnings growing at 19% annually. Revenues have been declining at an average rate of 171.6% per year.
Belangrijke informatie
-23.5%
Groei van de winst
8.2%
Groei van de winst per aandeel
| Biotechs Groei van de industrie | 17.0% |
| Inkomstengroei | -171.6% |
| Rendement op eigen vermogen | -61.3% |
| Nettomarge | n/a |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Geen updates
Opbrengsten en kosten
Hoe Instil Bio geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 0 | -120 | 50 | 20 |
| 31 Mar 24 | 0 | -123 | 50 | 26 |
| 31 Dec 23 | 0 | -156 | 51 | 39 |
| 30 Sep 23 | 0 | -197 | 57 | 54 |
| 30 Jun 23 | 0 | -186 | 62 | 85 |
| 31 Mar 23 | 0 | -226 | 67 | 118 |
| 31 Dec 22 | 0 | -223 | 69 | 137 |
| 30 Sep 22 | 0 | -225 | 64 | 160 |
| 30 Jun 22 | 0 | -211 | 60 | 149 |
| 31 Mar 22 | 0 | -188 | 57 | 129 |
| 31 Dec 21 | 0 | -157 | 51 | 104 |
| 30 Sep 21 | 0 | -119 | 44 | 74 |
| 30 Jun 21 | 0 | -83 | 33 | 50 |
| 31 Mar 21 | 0 | -57 | 21 | 31 |
| 31 Dec 20 | 0 | -38 | 13 | 18 |
Kwaliteitswinsten: TIL is currently unprofitable.
Groeiende winstmarge: TIL is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: TIL is unprofitable, and losses have increased over the past 5 years at a rate of 23.5% per year.
Versnelling van de groei: Unable to compare TIL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: TIL is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-2.3%).
Rendement op eigen vermogen
Hoge ROE: TIL has a negative Return on Equity (-61.32%), as it is currently unprofitable.